Intensified tonsil allergy shots for dust mite allergic rhinitis
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new way of giving allergy shots directly into the tonsils to treat dust mite allergies that cause runny nose, sneezing, and itchy eyes. It aims to see if this method is safer and works better than standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with allergic rhinitis from dust mites, confirmed by a skin test or blood test.
- You are between 5 and 60 years old.
- You have not had any allergy shots (under the skin or under the tongue) in the last year.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have serious health problems like heart disease, lung disease, immune disorders, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat allergies by injecting allergy medicine directly into the tonsils. It may help people with hay fever who haven't gotten relief from standard treatments or want to avoid long-term medication.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
This study tests whether heating tissue in the nose (radiofrequency ablation) followed by allergy treatment under the skin (immunotherapy) can reduce long-lasting nasal congestion from dust mite allergy. It may help patients whose symptoms are severe and who have not been able to get enough relief with recent allergy medicines.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.